Skip to content

World Scan Project, Inc.: 10-Q filed 2025-09-18

What World Scan Project, Inc. reported in its quarterly report filed 2025-09-18 (fiscal Q2 2025): 31 published measures, 99 facts as tagged in accession 0001813744-25-000008.

This filing

Form
10-Q (quarterly report)
Filed
2025-09-18
Fiscal period
fiscal Q2 2025
Accession
0001813744-25-000008 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All World Scan Project, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-04-3025,799,137USD
At 2024-10-3127,410,251USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-04-302,043,691USD
At 2024-10-3110,826,845USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-04-30120,263USD
At 2024-10-311,634,200USD
At 2024-04-30231,669USD
At 2023-10-315,698,883USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-02-01 to 2025-04-30212,390USD89
2024-11-01 to 2025-04-30314,359USD181
2024-11-01 to 2025-01-31101,969USD92
2024-02-01 to 2024-04-30110,275USD90
2023-11-01 to 2024-04-30-197,986USD182
2023-11-01 to 2024-01-31-308,261USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-11-01 to 2025-04-30-6,749,870USD181
2023-11-01 to 2024-04-30-10,588,393USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-02-01 to 2025-04-304,587,644USD89
2024-11-01 to 2025-04-308,671,654USD181
2024-02-01 to 2024-04-304,220,871USD90
2023-11-01 to 2024-04-3010,856,066USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-11-01 to 2025-04-305,244,000USD181
2023-11-01 to 2024-04-305,832,000USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-11-01 to 2024-04-30-427,412USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-04-308,684,483USD
At 2024-10-318,370,124USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-02-01 to 2025-04-3011,997,350shares89
2024-11-01 to 2025-04-3011,877,035shares181
2024-02-01 to 2024-04-3010,822,811shares90
2023-11-01 to 2024-04-3010,820,035shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-02-01 to 2025-04-3021,997,350shares89
2024-11-01 to 2025-04-3021,877,035shares181
2024-02-01 to 2024-04-3020,822,811shares90
2023-11-01 to 2024-04-3020,820,035shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-02-01 to 2025-04-300.02USD/shares89
2024-11-01 to 2025-04-300.03USD/shares181
2024-02-01 to 2024-04-300.01USD/shares90
2023-11-01 to 2024-04-30-0.02USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-02-01 to 2025-04-300.01USD/shares89
2024-11-01 to 2025-04-300.01USD/shares181
2024-02-01 to 2024-04-300.01USD/shares90
2023-11-01 to 2024-04-30-0.01USD/shares182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-02-01 to 2025-04-30183,547USD89
2024-11-01 to 2025-04-30158,573USD181
2024-02-01 to 2024-04-30-15,055USD90
2023-11-01 to 2024-04-30-79,374USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-04-3022,688,157USD
At 2024-10-3124,387,411USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-04-301,555,429USD
At 2024-10-3110,360,202USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-04-3090,115USD
At 2024-10-3185,882USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-02-01 to 2025-04-301,380,450USD89
2024-11-01 to 2025-04-302,767,804USD181
2024-02-01 to 2024-04-301,321,757USD90
2023-11-01 to 2024-04-303,084,343USD182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-04-3016,136,568USD
At 2024-10-3117,045,647USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-02-01 to 2025-04-301,780,076USD89
2024-11-01 to 2025-04-303,243,420USD181
2024-02-01 to 2024-04-301,415,192USD90
2023-11-01 to 2024-04-302,901,630USD182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-02-01 to 2025-04-302,807,568USD89
2024-11-01 to 2025-04-305,428,234USD181
2024-02-01 to 2024-04-302,805,679USD90
2023-11-01 to 2024-04-307,954,436USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-02-01 to 2025-04-30164,565USD89
2024-11-01 to 2025-04-30325,030USD181
2024-02-01 to 2024-04-30132,017USD90
2023-11-01 to 2024-04-30311,642USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-04-3011,997,350shares
At 2025-01-3111,997,350shares
At 2024-10-3111,560,350shares
At 2024-04-3011,303,350shares
At 2024-01-3110,817,350shares
At 2023-10-3110,817,350shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-04-3015,873,803USD
At 2024-10-3110,629,847USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-04-3023,755,446USD
At 2025-01-3121,722,465USD
At 2024-10-3116,583,406USD
At 2024-04-3013,542,629USD
At 2024-01-318,620,613USD
At 2023-10-318,715,687USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2025-04-30461,726USD
At 2024-10-31436,572USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-02-01 to 2025-04-302,032,981USD89
2024-11-01 to 2025-04-301,928,040USD181
2024-02-01 to 2024-04-30-909,984USD90
2023-11-01 to 2024-04-30-1,005,058USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-02-01 to 2025-04-301,215,885USD89
2024-11-01 to 2025-04-302,442,774USD181
2024-02-01 to 2024-04-301,189,740USD90
2023-11-01 to 2024-04-302,772,701USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-11-01 to 2025-04-30305USD181
2023-11-01 to 2024-04-30124,770USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2024-11-01 to 2025-04-302,100,125USD181
2023-11-01 to 2024-04-30-7,049,338USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-11-01 to 2025-04-30-6,109,456USD181
2023-11-01 to 2024-04-30-659,978USD182

Inspect the source

Entity
World Scan Project, Inc. / CIK 0001813744
Captured
2026-09-21T17:28:25.000Z
SEC response SHA-256
6254f1f987cfbe901baa7d024e9ac9e67919152916ce13367a2df355ffc68456

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001813744.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))